Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32678431 | 1.00 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL32678430 | 1.00 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL19924614 | 1.00 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL238101 | 1.00 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL30797151 | 1.00 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL5157013 | 1.00 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL238100 | 1.00 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL11247489 | 0.85 | EPHX1 (0.53) | EPHX1 | |
| SCHEMBL11251253 | 0.78 | EPHX1 (0.35) | EPHX1 | |
| Triethyl Citrate SCHEMBL1326007 | 0.75 | CYP2D6 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025051371-A1 | A FRAGRANCE PASTILLE | SYMRISE AG (DE) | 2025-03-13 | — | — | WO | claimed |
| WO-2025045353-A1 | A FRAGRANCE POD | SYMRISE AG (DE) | 2025-03-06 | — | — | WO | claimed |
| WO-2025045354-A1 | A FRAGRANCE TABLET | SYMRISE AG (DE) | 2025-03-06 | — | — | WO | claimed |
| US-20240197223-A1 | ORAL CARE FLAVOUR FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2024-06-20 | — | — | US | claimed |
| US-20240164998-A1 | FRAGRANCE COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2024-05-23 | — | — | US | claimed |
| EP-4371550-A1 | FRAGRANCE COMPOSITION | Takasago International Corporation (JP) | 2024-05-22 | — | — | EP | claimed |
| EP-4347759-A1 | ORAL CARE FLAVOUR FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | Givaudan SA (CH) | 2024-04-10 | — | — | EP | claimed |
| CN-117396587-A | Oral care flavor and assessment method for improving relaxation state | 奇华顿股份有限公司 | 2024-01-12 | — | — | CN | claimed |
| US-11844854-B2 | Fragrance materials | THE PROCTER & GAMBLE COMPANY (US) | 2023-12-19 | — | — | US | claimed |
| CN-114713206-B | Preparation and application of imidazole ionic liquid functionalized star-type block polymer stationary phase | 沈阳工业大学 | 2023-11-14 | — | — | CN | claimed |
| EP-2931854-A1 | FRAGRANCE MATERIALS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| EP-2931235-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| US-20140179748-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-26 | — | — | US | claimed |
| US-20140170194-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| WO-2014093807-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| WO-2014093748-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| WO-2014093828-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| US-20140170102-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMAPNY (US) | 2014-06-19 | — | — | US | claimed |
| EP-2134377-B1 | FRAGRANCE DISPENSER | SYMRISE AG (DE) | 2012-07-18 | — | — | EP | claimed |
| WO-1995000040-A1 | STABILISING VOLATILE FLAVOURINGS | FIRMENICH SA (CH) | 1995-01-05 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140170102-A1 | Antiperspirant and Deodorant Compositions | DEK, QDPR, GPX4 | EPHX1 867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.